Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy
Giovanni Battista Gaeta, Roberta Termini(Apple (Israel)), Hamid Hasson(Vita-Salute San Raffaele University), Alessio Aghemo, Barbara Menzaghi(Ospedale di Circolo di Busto Arsizio), Alessia Giorgini(Università Cattolica del Sacro Cuore), M. Palma(Janssen (Italy)), Giuseppina Brancaccio, Gianpiero D’Offizi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani)
Cited by 3
Related Papers
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
|Hepatology|2012|405
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Impact of COVID-19 on global HCV elimination efforts
|Journal of Hepatology|2020|279